TABLE 1.
Baseline anthropometric and lifestyle parameters of participants.
| Parameter | All baseline (n = 391) |
ITT population (n = 292) |
| Female (n) | 265 | 199 |
| Male (n) | 126 | 93 |
| Age (years) | 50 ± 10 | 51 ± 10 |
| Weight (kg) | 76 ± 18 | 78 ± 19 |
| Height (m) | 1.7 ± 0.1 | 1.7 ± 0.1 |
| BMI (kg/m2) | 26.6 ± 5.2 | 27.1 ± 6.2 |
| Smokers (%) | 1.3 | 0.7 |
| CVD diagnosed excluding MACE (%) | 31.8 | 32.3 |
| CVD family history (%) | 51.6 | 50.0 |
| Diabetes diagnosed (%) | 8.8 | 7.8 |
| Diabetes family history (%) | 38.8 | 35.8 |
| Use of fish oil or LCn-3 PUFA supplementation (%) | 36.6 | 39.0 |
| Use of Statin or LCn-3 PUFA containing medication (%) | 11.8 | 12.3 |
| Use of other cholesterol or TG lowering supplement (%) | 12.8 | 13.7 |
| Exercising at least 150 min per week (%) | 65.7 | 66.1 |
| At least 2 seafood servings/week (%) | 33.0 | 32.5 |
| At least 14 alcoholic drinks/week (%) | 3.8 | 4.5 |
| At least 4 caffeinated drinks/day (%) | 4.6 | 5.5 |
CVD, cardiovascular disease; MACE, major adverse cardiovascular events. Values represented as mean ± SD. No significant differences were observed between the All Baseline group and the intention-to-treat ITT population (p < 0.05).